Oxyphenbutazone anhydrous
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384629This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A7D84513GV, chemically known as (+/-)-oxyphenbutazone anhydrous, but more generally known as oxyphenbutazone anhydrous, which bears US NIH Compound Identifier 4641. European Medicines Agency schedules oxyphenbutazone anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09572MIG. Most nations, for tariff purposes, schedule oxyphenbutazone anhydrous under HS 29331990. Oxyphenbutazone anhydrous bears US NLM identifiers UMLS ID C2698680 and NCI Concept Code C74597. SMILES: CCCCC1C(=O)N(N(C1=O)C2CCC(CC2)O)C3CCCCC3.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.